CUSTOMER SUPPORT

4DMEDICAL

Latest News

Learn about 4DMedical’s latest developments and future projects as well—all aimed at significantly improving early detection, diagnosis, and therapeutic strategies for a range of pulmonary conditions, including chronic obstructive pulmonary disease (COPD), asthma, and lung cancer.
4DMedical’s CT:VQ™ technology combines the anatomical clarity of CT with functional ventilation-perfusion mapping from routine non-contrast CT scans, giving clinicians quantitative insights into regional lung function without radiotracers.
30 March 2026

4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union

4DMedical Limited (ASX:4DX), the global leader in cardiothoracic imaging software, announces that its latest imaging technology, CT:VQ™ has received CE Mark certification for commercial use in the European Union. 4DMedical will quickly launch commercial deployment of CT:VQ across one of the world's largest respiratory imaging markets.
READ MORE
The Surprising Faces of Lung Disease
29 March 2026

Not Just for Smokers: The Surprising Faces of Lung Disease

We may all be guilty of picturing the same person when we hear that someone has lung cancer—an older man who smoked for many years. The truth is, millions of people with lung disease have never smoked a single cigarette. Children, women who have never smoked, and even athletes can
READ MORE
Lung Function
21 February 2026

Lung Imaging in 2026: How Functional CT and New Investments Are Changing the Game

Lung disease is a global health challenge. Conditions like COPD, emphysema, and lung cancer affect hundreds of millions of people worldwide, yet many patients are still being diagnosed too late. Traditional imaging has focused on structure: identifying nodules, masses, or obvious tissue changes. In 2026, the field is rapidly evolving
READ MORE
4DMedical CT:VQ - Ventilation and Perfusion Analysis - Maximum Contrast and No Injections
20 January 2026

4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging

Funding will scale hospital deployments for groundbreaking CT:VQ™ imaging product, strongly advance R&D, support early adopters at Stanford, Cleveland Clinic, University of Miami, UC San Diego Health, and more 4DMedical, the leader in software-based respiratory imaging technology, today announced US$100+ million (AU$150 million) in new institutional placement. The investment will
READ MORE
4DMedical CT:VQ - Ventilation and Perfusion Analysis - Maximum Contrast and No Injections
19 December 2025

Aunt Minnie: 4DMedical inks major distribution agreement for CT:VQ™

New coverage from AuntMinnie.com: Philips will distribute 4DMedical’s CT:VQ™ across healthcare systems in the U.S. and Canada, expanding access to non-contrast CT-based ventilation and perfusion mapping.
READ MORE
Early COPD Detection
10 October 2025

Catching COPD Early: Why Timing Could Save Your Lungs

Chronic Obstructive Pulmonary Disease, or COPD, is one of the most common lung conditions in the world—yet it remains deeply underdiagnosed. In the United States alone, over 12.5 million people are known to have COPD, but millions more may be living with it. One of the main reasons for this
READ MORE
4DMedical CT:VQ - Then: Structural Only and Now: See the Physiology
12 September 2025

CT:VQ™ Redefines Lung Imaging: FDA Clearance Makes Non-Contrast V/Q Scans a Reality

In a landmark move for pulmonary diagnostics, 4DMedical’s CT:VQ™ earned FDA 510(k) clearance in September 2025, marking it as the first and only non-contrast ventilation–perfusion (V/Q) imaging solution. The technology is available via routine chest CT scans. With CMS confirming reimbursement under Category III CPT codes (on top of the
READ MORE
CT:VQ™ Non-Contrast Lung Ventilation Perfusion
04 September 2025

4DMedical’s CT:VQ™ Receives FDA 510(k) Clearance; First-and-Only Non-Contrast VQ Imaging

4DMedical, a leader in advanced respiratory imaging, today announces U.S. Food and Drug Administration (FDA) 510(k) clearance for CT:VQ™, the world’s first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the U.S. Centers for Medicare & Medicaid Services (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes;
READ MORE
01 September 2025

April 16-19 | Canadian Association of Radiologist (CAR) | Montréal, Canada

The CAR 2026 Annual Scientific Meeting, hosted by the Canadian Association of Radiologists, is Canada’s leading event for medical imaging professionals. Taking place April 16–19, 2026 at Le Westin Montréal in Montréal, Québec, CAR 2026 brings together radiologists, researchers, residents, and industry partners for four days of high-impact scientific programming,
READ MORE

What's new at 4DMedical

Get the latest news about respiratory imaging and ventilation analysis
CUSTOMER SUPPORT